Fate Therapeutics
FATE
#8356
Rank
โ‚น27.79 B
Marketcap
โ‚น238.48
Share price
-1.98%
Change (1 day)
115.57%
Change (1 year)

Fate Therapeutics (FATE) Fails to deliver data

Key failure to deliver metrics for Fate Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Fate Therapeutics (FATE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Fate Therapeutics (FATE) - since 2013

Volume in USD (price x number of shares), data since 2013

Fate Therapeutics (FATE) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026โ‚น0.44 M-68.1%
2025โ‚น1.38 M14.86%
2024โ‚น1.2 M-44.15%
2023โ‚น2.15 M-89.19%
2022โ‚น19.92 M-20.28%
2021โ‚น24.99 M31.2%
2020โ‚น19.05 M9.95%
2019โ‚น17.32 M59.52%
2018โ‚น10.86 M1415.4%
2017โ‚น0.71 M181.93%
2016โ‚น0.25 M-79.05%
2015โ‚น1.21 M-17.49%
2014โ‚น1.47 M-81.78%
2013โ‚น8.07 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Becton Dickinson
BDX
โ‚น79.82 Mโ‚น0.13 B๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น12.05 Mโ‚น24.23 M๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
โ‚น15.65 Mโ‚น33.24 M๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น92.41 Mโ‚น0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
N/Aโ‚น38.89 M๐Ÿ‡บ๐Ÿ‡ธ USA